中国药物经济学2025，Vol.20Issue(8)：29-32,66,5.DOI:10.12010/j.issn.1673-5846.2025.08.005
治伤胶囊与伤科接骨片治疗急性软组织损伤的药物经济学评价
Pharmacoeconomic Evaluation of Zhisang Capsules and Orthopedic Bone Tablets in the Treatment of Acute Soft Tissue Injuries
张艳玲 1唐建飞 2范仲姝2
作者信息
- 1. 中国中医科学院西苑医院,北京 100091
- 2. 杭州朱养心药业有限公司,杭州 310018
- 折叠
摘要
Abstract
Objective To evaluate the economic viability of Zhishang Capsules and Orthopedic Bone Tablets in the treatment of acute soft tissue injuries.Methods Based on the meta-analysis results of this study,from the perspective of the medical system as the research Angle,the decision tree model was used to conduct a cost-effectiveness analysis of the treatment of acute soft tissue injuries with Zhishang Capsules and Orthopedic bone Tablets,and a sensitivity analysis was also carried out.Results The results of the meta-analysis showed that the effective rate of Zhishang Capsules in treating acute soft tissue injuries was 95.24%,which was higher than that of Orthopedic bone Tablets at 84.38%(P＜0.05).The cost-effectiveness analysis results show that compared with orthopedic bone tablets,Zhishang Capsules have lower costs and better effects in treating acute soft tissue injuries,and are a treatment plan with absolute economic advantages.To further verify the reliability and stability of the results,a single-sensitivity analysis was conducted.The results showed that the stability of the basic analysis results was good.Conclusion Zhishang Capsules,with their excellent safety,significant efficacy and outstanding economy,offer a high-quality,efficient and economical drug option for the clinical treatment of acute soft tissue injuries.关键词
急性软组织损伤/治伤胶囊/伤科接骨片/成本-效果分析Key words
Acute soft tissue injury/Zhishang Capsules/Orthopedic Bone Tablets/Cost-effectiveness analysis分类
医药卫生引用本文复制引用
张艳玲,唐建飞,范仲姝..治伤胶囊与伤科接骨片治疗急性软组织损伤的药物经济学评价[J].中国药物经济学,2025,20(8):29-32,66,5.
